This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

U.S. Physical Therapy Reports Second Quarter And Six Months Results

Second Quarter 2012 compared to Second Quarter 2011

  • Net revenues increased 6.8% from $59,912,000 in the second quarter of 2011 to $63,959,000 in the second quarter of 2012, primarily due to an increase in patient visits of 8.6% from 541,000 to 587,000. The average net patient revenue per visit for the recent quarter was $105.65 as compared to $104.77 in the comparable 2011 period. The increase in net revenues from the Company’s core physical therapy operations was partially offset by a decrease in other revenues of $1,300,000 due to a reduction in revenue from physician services.
  • Total clinic operating costs were $46,965,000, or 73.4% of net revenues, in the second quarter of 2012, as compared to $43,023,000, or 71.8% of net revenues, in the 2011 period. Clinic salaries and related costs were 51.1% of net revenues in the recent quarter versus 51.9% in the 2011 period. Rent, clinic supplies, contract labor and other costs as a percentage of net revenues were 20.3% for the recent quarter versus 19.0% in the 2011 period. The provision for doubtful accounts as a percentage of net revenues was 2.0% for the 2012 period versus 0.8% in the 2011 quarter. In the second quarter of 2012 the gross margin from the Company’s core physical therapy business increased by $1,631,000 or 10.5% as compared to the second quarter of 2011 which was offset by a $1,526,000 decrease in margin from the physician services business.
  • Corporate office costs were $6,396,000 in the second quarter of 2012 as compared to $6,007,000 in the 2011 second quarter. Corporate office costs were 10.0% of net revenues in both periods.
  • Operating income for the second quarter of 2012 was $10,598,000 compared to $10,882,000 in the 2011 second quarter.
  • Interest expense increased to $145,000 in the second quarter of 2012 from $109,000 in the second quarter of 2011 due to higher average borrowings in the 2012 period.
  • Net income attributable to non-controlling interests was $2,465,000 in the recent quarter as compared to $2,703,000 in the year earlier period. The reduction is attributable to the Company’s increased ownership interest in certain of its physical therapy partnerships.
  • Provision for income taxes as a percentage of income before taxes less net income attributable to non-controlling interests was 39.3% in both the 2012 and 2011 periods.
  • Reported net income attributable to common shareholders in the second quarter of 2012 was $4,849,000 compared to $4,900,000 in the second quarter of 2011. Diluted earnings per share were $0.41 for both periods.
  • Same store revenues for de novo and acquired clinics open for one year or more increased 2.8%. Higher same store visits and higher average net rate per visit accounted for the increase.

Chris Reading, Chief Executive Officer, said, “So far this year the performance of our core physical therapy business has been strong with solid same store net rate, revenue and earnings growth. Patient visit growth followed a similar trajectory increasing an average of one patient per clinic per day. In the second quarter, the Company’s net rate per visit increased to $105.65. Management is making adjustments designed to improve our physician services performance which has seen a reduction in earnings thus far in 2012 as compared to 2011. While there is much opportunity to capture and work yet to be done, we remain confident in our ability to execute on our plan and accordingly we are increasing our earnings guidance.”

Stock quotes in this article: USPH 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 +2.54 0.14%
NASDAQ 4,095.5160 +9.2910 0.23%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs